Skip to main navigation Skip to search Skip to main content

Drug Delivery to Wounds, Burns, and Diabetes-Related Ulcers

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

The skin’s continuity and integrity can be compromised as a result of trauma arising from physical or thermal damage or an underlying pathological condition resulting in wounds. Wound healing involves three phases: inflammation, proliferation (new tissue formation), and remodeling/contraction. This chapter discussed different wound management dressings and advanced technologies for achieving improved healing for wounds, burns, and diabetes-related ulcers. Several dressings have been used for delivering drugs to acute and chronic wounds. Apart from the dressings, some pharmacological agents that include antibiotic, gene therapy and cytokine, growth factors, and stem cells and other drugs like antioxidants, antihistamines, phenytoin, antisense gel, and traditional drugs have been discussed in the chapter along with the pathogenesis of wounds, burns, and diabetes ulcers.
Original languageAmerican English
Title of host publicationFocal Controlled Drug Delivery
EditorsAbraham J. Domb, Wahid Khan
Place of PublicationBoston, MA
PublisherSpringer US; Imprint: Springer
Pages585-605
Number of pages21
ISBN (Print)978-1-4614-9434-8
DOIs
StatePublished - 2014

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Drug Delivery to Wounds, Burns, and Diabetes-Related Ulcers'. Together they form a unique fingerprint.

Cite this